Biomedical Engineering Reference
In-Depth Information
89. Martin C, Higgins CF, Callaghan R. 2001. The vinblastine binding site adopts high-
and low-affinity conformations during a transport cycle of P-glycoprotein. Biochemistry
40:15733-15742.
90. Sharom FJ, Russell PL, Qu Q, Lu P. 2003. Fluorescence techniques for studying mem-
brane transport proteins: the P-glycoprotein multidrug transporter. Methods Mol Biol 227:
109-128.
91. Sharom FJ, Liu R, Romsicki Y, Lu P. 1999. Insights into the structure and substrate inter-
actions of the P-glycoprotein multidrug transporter from spectroscopic studies. Biochim
Biophys Acta 1461:327-345.
92. Tanigawara Y, Okamura N, Hirai M, Yasuhara M, Ueda K, Kioka N, Komano T, Hori
R. 1992. Transport of digoxin by human P-glycoprotein expressed in a porcine kidney
epithelial cell line (LLC-PK1). J Pharmacol Exp Ther 263:840-845.
93. Hunter J, Jepson MA, Tsuruo T, Simmons NL, Hirst BH. 1993. Functional expression
of P-glycoprotein in apical membranes of human intestinal Caco-2 cells: kinetics of
vinblastine secretion and interaction with modulators. J Biol Chem 268:14991-14997.
94. Saeki T, Ueda K, Tanigawara Y, Hori R, Komano T. 1993. Human P-glycoprotein trans-
ports cyclosporin A and FK506. J Biol Chem 268:6077-6080.
95. Ueda K, Okamura N, Hirai M, Tanigawara Y, Saeki T, Kioka N, Komano T, Hori R.
1992. Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but
not progesterone. J Biol Chem 267:24248-24252.
96. Saeki T, Ueda K, Tanigawara Y, Hori R, Komano T. 1993. P-glycoprotein-mediated
transcellular transport of MDR-reversing agents. FEBS Lett 324:99-102.
97. Ueda K, Saeki T, Hirai M, Tanigawara Y, Tanaka K, Okamura M, Yasuhara M, Hori R,
Inui K, Komano T. 1994. Human P-glycoprotein as a multi-drug transporter analyzed by
using transepithelial transport system. Jpn J Physiol 44 (Suppl 2):S67-S71.
98. Hirai M, Tanaka K, Shimizu T, Tanigawara Y, Yasuhara M, Hori R, Kakehi Y, Yoshida
O, Ueda K, Komano T. 1995. Cepharanthin, a multidrug resistant modifier, is a substrate
for P-glycoprotein. J Pharmacol Exp Ther 275:73-78.
99. Horio M, Gottesman MM, Pastan I. 1988. ATP-dependent transport of vinblastine in
vesicles from human multidrug-resistant cells. Proc Natl Acad Sci U S A 85:3580-3584.
100. Kamimoto Y, Gatmaitan Z, Hsu J, Arias IM. 1989. The function of Gp170, the mul-
tidrug resistance gene product, in rat liver canalicular membrane vesicles. J Biol Chem
264:11693-11698.
101. Tamai I, Safa AR. 1990. Competitive interaction of cyclosporins with the vinca alkaloid-
binding site of P-glycoprotein in multidrug-resistant cells. J Biol Chem 265:16509-16513.
102. Horio M, Lovelace E, Pastan I, Gottesman MM. 1991. Agents which reverse multidrug-
resistance are inhibitors of [
3
H]vinblastine transport by isolated vesicles. Biochim Bio-
phys Acta 1061:106-110.
103. Piwnica-Worms D, Rao VV, Kronauge JF, Croop JM. 1995. Characterization of multidrug
resistance P-glycoprotein transport function with an organotechnetium cation. Biochem-
istry 34:12210-12220.
104. Shapiro AB, Corder AB, Ling V. 1997. P-glycoprotein-mediated Hoechst 33342 transport
out of the lipid bilayer. Eur J Biochem 250:115-121.
105. Lu P, Liu R, Sharom FJ. 2001. Drug transport by reconstituted P-glycoprotein in prote-
oliposomes: effect of substrates and modulators, and dependence on bilayer phase state.
Eur J Biochem 268:1687-1697.
Search WWH ::
Custom Search